114 related articles for article (PubMed ID: 1719384)
1. Mutations in the C-terminal part of insulin-like growth factor (IGF)-binding protein-1 result in dimer formation and loss of IGF binding capacity.
Brinkman A; Kortleve DJ; Zwarthoff EC; Drop SL
Mol Endocrinol; 1991 Jul; 5(7):987-94. PubMed ID: 1719384
[TBL] [Abstract][Full Text] [Related]
2. Site-directed mutagenesis of the N-terminal region of IGF binding protein 1; analysis of IGF binding capability.
Brinkman A; Kortleve DJ; Schuller AG; Zwarthoff EC; Drop SL
FEBS Lett; 1991 Oct; 291(2):264-8. PubMed ID: 1718783
[TBL] [Abstract][Full Text] [Related]
3. Macrophages synthesize and secrete a 25-kilodalton protein that binds insulin-like growth factor-I.
Li YM; Arkins S; McCusker RH; Donovan SM; Liu Q; Jayaraman S; Dantzer R; Kelley KW
J Immunol; 1996 Jan; 156(1):64-72. PubMed ID: 8598495
[TBL] [Abstract][Full Text] [Related]
4. Regulation of insulin-like growth factor binding protein-3 messenger ribonucleic acid expression by insulin-like growth factor I.
Bale LK; Conover CA
Endocrinology; 1992 Aug; 131(2):608-14. PubMed ID: 1379162
[TBL] [Abstract][Full Text] [Related]
5. Competition for binding to insulin-like growth factor (IGF) binding protein-2, 3, 4, and 5 by the IGFs and IGF analogs.
Clemmons DR; Dehoff ML; Busby WH; Bayne ML; Cascieri MA
Endocrinology; 1992 Aug; 131(2):890-5. PubMed ID: 1379166
[TBL] [Abstract][Full Text] [Related]
6. Structural aspects of the IGFBP family.
Drop SL; Schuller AG; Lindenbergh-Kortleve DJ; Groffen C; Brinkman A; Zwarthoff EC
Growth Regul; 1992 Jun; 2(2):69-79. PubMed ID: 1283100
[TBL] [Abstract][Full Text] [Related]
7. Recombinant human insulin-like growth factor binding proteins 4, 5, and 6: biological and physiochemical characterization.
Kiefer MC; Schmid C; Waldvogel M; Schläpfer I; Futo E; Masiarz FR; Green K; Barr PJ; Zapf J
Growth Regul; 1993 Mar; 3(1):56-9. PubMed ID: 7683532
[TBL] [Abstract][Full Text] [Related]
8. Diversity of human insulin-like growth factor (IGF) binding protein-2 fragments in plasma: primary structure, IGF-binding properties, and disulfide bonding pattern.
Mark S; Kübler B; Höning S; Oesterreicher S; John H; Braulke T; Forssmann WG; Ständker L
Biochemistry; 2005 Mar; 44(9):3644-52. PubMed ID: 15736974
[TBL] [Abstract][Full Text] [Related]
9. Regulation of insulin-like growth factor binding protein synthesis and secretion in a bovine epithelial cell line.
Cohick WS; Clemmons DR
Endocrinology; 1991 Sep; 129(3):1347-54. PubMed ID: 1714831
[TBL] [Abstract][Full Text] [Related]
10. Insulin-like growth factor-binding protein enhancement of insulin-like growth factor-I (IGF-I)-mediated DNA synthesis and IGF-I binding in a human breast carcinoma cell line.
Chen JC; Shao ZM; Sheikh MS; Hussain A; LeRoith D; Roberts CT; Fontana JA
J Cell Physiol; 1994 Jan; 158(1):69-78. PubMed ID: 7505280
[TBL] [Abstract][Full Text] [Related]
11. Structural basis for the inhibition of insulin-like growth factors by insulin-like growth factor-binding proteins.
Sitar T; Popowicz GM; Siwanowicz I; Huber R; Holak TA
Proc Natl Acad Sci U S A; 2006 Aug; 103(35):13028-33. PubMed ID: 16924115
[TBL] [Abstract][Full Text] [Related]
12. Cloning and sequence determination of bovine insulin-like growth factor binding protein-2 (IGFBP-2): comparison of its structural and functional properties with IGFBP-1.
Bourner MJ; Busby WH; Siegel NR; Krivi GG; McCusker RH; Clemmons DR
J Cell Biochem; 1992 Feb; 48(2):215-26. PubMed ID: 1377702
[TBL] [Abstract][Full Text] [Related]
13. Functional analysis of glucocorticoid and insulin response sequences in the rat insulin-like growth factor-binding protein-1 promoter.
Goswami R; Lacson R; Yang E; Sam R; Unterman T
Endocrinology; 1994 Feb; 134(2):736-43. PubMed ID: 7507835
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the affinities of insulin-like growth factor (IGF)-binding proteins 1-4 for IGF-I, IGF-II, IGF-I/insulin hybrid, and IGF-I analogs.
Oh Y; Müller HL; Lee DY; Fielder PJ; Rosenfeld RG
Endocrinology; 1993 Mar; 132(3):1337-44. PubMed ID: 7679979
[TBL] [Abstract][Full Text] [Related]
15. Identification of the major sites of phosphorylation in IGF binding protein-3.
Hoeck WG; Mukku VR
J Cell Biochem; 1994 Oct; 56(2):262-73. PubMed ID: 7530253
[TBL] [Abstract][Full Text] [Related]
16. Mutagenesis of basic amino acids in the carboxyl-terminal region of insulin-like growth factor binding protein-5 affects acid-labile subunit binding.
Firth SM; Clemmons DR; Baxter RC
Endocrinology; 2001 May; 142(5):2147. PubMed ID: 11316783
[TBL] [Abstract][Full Text] [Related]
17. Cloning of the rat insulin-like growth factor-binding protein-2 gene and identification of a functional promoter lacking a TATA box.
Brown AL; Rechler MM
Mol Endocrinol; 1990 Dec; 4(12):2039-51. PubMed ID: 1707131
[TBL] [Abstract][Full Text] [Related]
18. Differential effects of insulin-like growth factor (IGF)-I and IGF-II on the expression of IGF binding proteins (IGFBPs) in a rat neuroblastoma cell line: isolation and characterization of two forms of IGFBP-4.
Ceda GP; Fielder PJ; Henzel WJ; Louie A; Donovan SM; Hoffman AR; Rosenfeld RG
Endocrinology; 1991 Jun; 128(6):2815-24. PubMed ID: 1709857
[TBL] [Abstract][Full Text] [Related]
19. Cumulative mutagenesis of the basic residues in the 201-218 region of insulin-like growth factor (IGF)-binding protein-5 results in progressive loss of both IGF-I binding and inhibition of IGF-I biological action.
Allan GJ; Tonner E; Szymanowska M; Shand JH; Kelly SM; Phillips K; Clegg RA; Gow IF; Beattie J; Flint DJ
Endocrinology; 2006 Jan; 147(1):338-49. PubMed ID: 16195401
[TBL] [Abstract][Full Text] [Related]
20. The effects of site-directed mutagenesis on the dimerization and secretion of the NS1 protein specified by dengue virus.
Pryor MJ; Wright PJ
Virology; 1993 Jun; 194(2):769-80. PubMed ID: 8389081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
